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ABSTRACT
Interleukin-1 (IL-1), the ‘gatekeeper’ of inflammation, is the apical
cytokine in a signalling cascade that drives the early response to
injury or infection. Expression, processing and secretion of IL-1 are
tightly controlled, and dysregulated IL-1 signalling has been
implicated in a number of pathologies ranging from atherosclerosis
to complications of infection. Our understanding of these processes
comes from in vitro monocytic cell culture models as lines or primary
isolates, in which a range and spectra of IL-1 secretion mechanisms
have been described. We therefore investigated whether zebrafish
embryos provide a suitable in vivo model for studying IL-1-mediated
inflammation. Structurally, zebrafish IL-1β shares a β-sheet-rich trefoil
structure with its human counterpart. Functionally, leukocyte
expression of IL-1β was detectable only following injury, which
activated leukocytes throughout zebrafish embryos. Migration of
macrophages and neutrophils was attenuated by inhibitors of either
caspase-1 or P2X7, which similarly inhibited the activation of NF-κB
at the site of injury. Zebrafish offer a new and versatile model to study
the IL-1β pathway in inflammatory disease and should offer unique
insights into IL-1 biology in vivo.
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INTRODUCTION
Interleukin-1 (IL-1) is an important activator of inflammation.
Dysregulated IL-1β function has been described in the pathology of
a number of auto- or chronic inflammatory diseases, leading to this
cytokine being described as the ‘gatekeeper’ of inflammation
(Dinarello, 2011c). Despite its key role in initiating inflammation,
many aspects of IL-1β activity remain poorly understood, in part due
to its unconventional secretion mechanism but also due to the
complex array of proteins involved in its activation (Schroder and
Tschopp, 2010). In macrophages, IL-1β transcription is induced and
IL-1β mRNA stabilised following detection of pathogen-derived
Toll-like receptor (TLR) ligands (Bufler et al., 2004). Processing and
secretion of inactive pro-IL-1β requires a secondary stimulus, the
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best-studied being ATP, a key damage-associated molecular pattern
(DAMP) (Lister et al., 2007). ATP activates the P2X7 receptor,
resulting in rapid assembly of the inflammasome, an IL-1β-
activation and -processing platform. IL-1β is thereby processed into
its active form, with concomitant secretion (Rathinam et al., 2012).
IL-1β secretion is proposed to occur via a number of different
mechanisms, ranging from lysosomal and microvesicular to
pyroptotic, dependent on the strength of the inflammatory stimulus
and the cell type in question (López-Castejón and Brough, 2011).
Our understanding of these mechanisms is built predominantly on
cell-culture studies of various cell types, although, additionally,
animal models have been used to evaluate the requirement of
specific proteins in IL-1β-mediated inflammation (Horai et al., 2000;
Kuida et al., 1995). However, it has not been possible to combine
the key features of such models to determine, in an intact organism,
the vesicular component of IL-1β secretion and how IL-1β is
specifically targeted to effector cells.
The evolutionary origins of innate immunity predate the first
vertebrates, with cytokine signalling pathways detected in simple
organisms (Beck and Habicht, 1991). Much of the complexity of the
human immune system is well established in ray-finned fish, making
zebrafish a tractable model to study innate immunity and
inflammation in vivo (Renshaw and Trede, 2012). Importantly,
zebrafish possess orthologues of the known components of IL-1β
signalling, including TLRs, NF-κB, IL-1 receptors I and II, and
P2X7 (Huising et al., 2004; López-Castejón et al., 2007; Stein et al.,
2007). Here, we use the zebrafish model, Danio rerio, to study IL-
1β signalling, and demonstrate its value as a model of IL-1β biology
through characterising the induction of IL-1β in response to injury
and the attenuation of inflammatory signals through the use of
inhibitors of the IL-1β pathway.
RESULTS
Zebrafish and human IL-1β are structurally conserved
Previous studies describing the use of the zebrafish as a tool for
investigating IL-1β have highlighted the differences between
zebrafish and human IL-1β; specifically, the lack of a conserved
caspase-1 cleavage site on the zebrafish homologue (Bird et al.,
2002). The two proteins share only 27% amino acid identity, but we
observed greater identity (31%) in the C-terminal domain,
representing the mature cytokine. We submitted the zebrafish IL-1β
sequence to the Phyre structural prediction server (Kelley and
Sternberg, 2009) generating a β-sheet-rich trefoil structure closely
matching that of the mature human cytokine (supplementary
material Fig. S1).
IL-1β message is induced in leukocytes throughout the
zebrafish in response to injury
Having determined structural conservation of zebrafish IL-1β to its
mammalian orthologues, we studied its expression and regulation in
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developing zebrafish. We hypothesised that the tight control of IL-
1β translation by regulation of message abundance is only removed
in response to inflammatory stimuli, as in mammalian systems
(Bufler et al., 2004). No IL-1β mRNA was detected in unstimulated
embryos or larvae at 24 or 48 hours post-fertilisation (hpf) using
whole-mount in situ hybridisation (WISH) (Fig. 1A); however,
when we probed embryos fixed at various stages after injury, we
observed high-intensity IL-1β mRNA staining (Fig. 1B) in cells with
a mononuclear morphology (Fig. 1Bi-Biii) characteristic of
macrophages. Recent evidence also supports the role of neutrophils
in IL-1β signalling (Basran et al., 2013). Using the neutrophil-
specific mpx:EGFP transgenic line, we sorted neutrophils and
control cells with comparable scatter characteristics from 6-week-
old zebrafish. Using microarray expression analysis, IL-1β mRNA
was detectable in zebrafish neutrophils at a level 4.9-times higher
than in control cells. Because IL-1β seemed to be expressed in both
neutrophils and macrophages, we further characterised IL-1β-
expressing cells by staining embryos for neutrophil and macrophage
markers [as described previously (Feng et al., 2010; Prajsnar et al.,
2012)] alongside fluorescent WISH for IL-1β. We detected IL-1β
colocalising with both neutrophil and macrophage markers
(Fig. 1C,D). The initial inflammatory response was characterised
predominantly by IL-1β expression in macrophages, and there were
fewer positively stained neutrophils (Fig. 1E). This pattern was
observed until 5 hours post-injury (hpi), after which expression
declined, supporting a role in zebrafish embryos for IL-1β in
inflammation initiation, as is characteristic in human disease
(Dinarello, 2011b). To further identify leukocyte-specific IL-1β
mRNA expression, we FACS-sorted mpeg:Gal4;UAS:Kaede-
labelled macrophages (Ellett et al., 2011) and mpx:EGFP-labelled
neutrophils (Renshaw et al., 2006), and observed very high
expression levels in both of these cell types by qRT-PCR (Fig. 1F).
IL-1β pathway inhibitors reduce leukocyte recruitment to
the site of injury
The early enhancement of IL-1β mRNA in inflammatory leukocytes
suggests a role in initiating the inflammatory response in the
zebrafish tailfin injury model. By analogy to mammalian IL-1β
processing and release, we tested the involvement of the
inflammasome in IL-1β processing by using inhibitors. The
recruitment of innate immune cells is a key feature of the
inflammatory response. We therefore developed an assay based on
macrophage and neutrophil recruitment following tissue injury.
Using an mpeg1:Gal4;UAS:Kaede reporter line we measured a
reduction in the number of macrophages recruited to the site of
injury after 6 hours when treated either with the caspase-1 inhibitor
YVAD or with the P2X7 antagonists KN62 or BBG (Fig. 2A,B).
The pan-caspase inhibitor qVD did not attenuate macrophage
recruitment, suggesting perhaps that the effect on inflammasome
inhibition might be balanced in vivo by suppression of normal
apoptosis. Neutrophil recruitment was similarly attenuated by
YVAD, Brilliant Blue G and KN62, whereas qVD had no significant
effect upon this response (Fig. 2C,D). The effect of IL-1β and P2X7
on macrophage recruitment was confirmed by morpholino
knockdown of IL-1β (Roca et al., 2008) and P2X7 (Chang et al.,
2011) (supplementary material Fig. S2).
The caspase-1 inhibitor YVAD reduces the activity of NF-κB
at the site of injury
Because IL-1β acts on target cells via the IL-1 receptor activating
NF-κB, we tested whether NF-κB signalling was sensitive to
treatment with inflammasome inhibitors. We generated a transgenic
line using the NF-κB reporter constructs previously described
(Kanther et al., 2011) and confirmed that, in this line, NF-κB was
activated in response to injury (Fig. 3A,B). Using this line, we
developed an inflammation assay based on quantification of the
mean fluorescent intensity at the site of tailfin transection and
observed that, when treated with the caspase-1 inhibitor YVAD, the
activation of NF-κB at the site of injury was significantly reduced
(Fig. 3C); this effect was not seen with the pan-caspase inhibitor
qVD. P2X7 antagonists showed a trend towards reduced NF-κB
activation, although this effect was not statistically significant (data
not shown).
The expression of IL-1β in response to tailfin injury is
reduced in response to treatment with IL-1β pathway
inhibitors
Using the assay developed by de Oliveira et al. (de Oliveira et al.,
2013), we investigated the expression of the same panel of
inflammatory genes in response to tail injury and the effect of
mammalian P2X7 and caspase-1 inhibitors BBG, KN62 and YVAD
on expression of these genes. We tested whether zebrafish IL-1β
induces its own downstream transcription, as described in numerous
mammalian models (Dinarello, 2011a; Dinarello et al., 1987;
Granowitz et al., 1992). We were able to detect the same induction
of IL-1β, IL-8a and ptgs2b following injury as previously reported
(de Oliveira et al., 2013) (supplementary material Fig. S3A-C). In
addition, we measured a significant decrease in the expression of IL-
1β but not IL-8 or ptgs2b in response to treatment with YVAD, BBG
or KN62 at 2 hpi (Fig. 4A). Taken together, these results
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TRANSLATIONAL IMPACT
Clinical issue 
Interleukin-1 (IL-1) is the apical cytokine in a signalling cascade that
drives the early inflammatory response to injury or infection. The
expression, processing and secretion of IL-1 is normally tightly regulated
and dysregulation of IL-1 is thought to underlie the chronic progressive
inflammation that results in atherosclerosis (leading to stroke and
myocardial infarction), type 2 diabetes and osteoarthritis. Based on in
vitro experiments, IL-1 is thought to be released into the circulation and
into tissues via several unusual and unconventional secretory
mechanism(s). In vitro, the mechanism of IL-1 secretion that is used is
dependent on cell type and on the strength of the inflammatory stimulus.
However, it is not known which secretion mechanism occurs
physiologically because IL-1 signalling has not been imaged in vivo. 
Results 
The evolutionary origins of human innate immunity predate the first
vertebrates and the immune system of ray-finned fish mirrors much of
the complexity of the human immune system. In this study, therefore, the
authors investigate whether zebrafish is a suitable in vivo model in which
to study IL-1 secretion and signalling. To this end, they show that the
predicted structure of the zebrafish IL-1 protein shares significant
similarities with the structure of human IL-1. They report that IL-1
mRNA levels are increased in zebrafish in response to injury. Finally, they
show that inhibitors of IL-1 processing prevent immune cell migration to
the site of injury in zebrafish.
Implications and future directions 
These findings support the functional conservation of IL-1 signalling
between the mammalian and teleost lineages, and identify zebrafish as
a new and versatile in vivo model in which to study the biology of IL-1,
the ‘gate-keeper’ of inflammation. The role of the specific pathways and
mechanisms that are required for IL-1 secretion and signalling in a live
intact physiological system can now be investigated using this model
species, which offers researchers the potential to identify anti-
inflammatory targets and to assess the effectiveness of potential
therapies for acute and chronic inflammation. 
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demonstrate that the zebrafish inflammatory response is sensitive to
inhibitors of inflammasome activity.
DISCUSSION
The investigation of IL-1β pathway biology has hitherto relied
primarily on in vitro cell-culture techniques. Observing these
processes in a living model could yield valuable insights into the
release mechanisms of this cytokine as the IL-1β-producing cells
interact with the cellular microenvironment in an inflammatory
lesion. These complex interactions are not accessible to conventional
monoculture techniques. Zebrafish are an ideal model for in vivo
observation of the vertebrate immune system (Henry et al., 2013),
although investigation of IL-1β in zebrafish has been confounded by
concerns relating to the conservation of IL-1β processing in the
zebrafish (Angosto et al., 2012). Recent publications have described
the cleavage of zebrafish IL-1β by the caspase-1 homologues
caspase-A and caspase-B (Vojtech et al., 2012), suggesting
conservation of IL-1β processing. The functional significance of
caspase activity in inflammation in zebrafish and the implications
for IL-1β function have not previously been explored. Here, we
describe the temporal induction of the IL-1β message in response to
injury and characterise this response in terms of the innate immune
cell lineages responsible. Comparable to mammalian data (Morris
et al., 2005), the primary IL-1β-expressing cell in the inflammatory
response following tail transection is the macrophage, although
neutrophils were also implicated.
The zebrafish innate immune response was reduced in magnitude
following treatment with inhibitors of P2X7, a key activator of IL-
1β processing in mammalian systems (Ward et al., 2010). These data
are supported by the reduction in both cellular and transcriptional
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Fig. 1. IL-1β expression is induced in leukocytes
throughout the embryo in response to injury. Expression
analysis of IL-1β by in situ hybridisation. (Ai) Embryos fixed
at 48 hours post-fertilisation (hpf) show no IL-1β expression
before injury, but IL-1β expression can be detected in cells
throughout the embryo 2 hours post injury (hpi) by tailfin
transection (Aii). Arrow indicates area represented in Bi,ii.
Scale bars: 500 μm. (Bi-ii) IL-1β expression at the site of
injury appears localised to cells with typical leukocyte
morphology: close up views of region represented in Aii by a
box in (Bi) 24 hpf embryos at 2 hpi and (Bii) 48 hpf embryos
2 hpi. Scale bars: 50 μm. (Biii) Magnified image of tail region:
IL-1β-positive cells have large nuclei and leukocytic
morphology. Scale bar: 20 μm. (C) 48-hpf embryos were
fixed and at 2 hpi were probed with anti-L-plastin (green;
labelling leukocytes), stained for endogenous neutrophil
peroxidase activity with Cy5 TSA (purple) and FISH
performed to detect IL-1β mRNA (red) to determine the
localisation of IL-1β in response to injury. Scale bars: 40 μm.
(D) Close-up of boxed area shown in C. Scale bars: 40 μm.
IL-1β was detected both in neutrophils (TSA+;L-plastin+,
white arrows) and macrophages (TSA–;L-plastin+, blue
arrows). (E) Quantification of IL-1β-expressing cells revealed
expression predominantly in macrophages at all time points
assayed (***P≤0.001 by multiple t-test with Bonferroni
correction, n=8 performed as two independent experiments).
(F) IL-1β was detected at very high levels by qRT-PCR in
FACS-isolated zebrafish leukocytes when normalised to
uninjured tail tissue.
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readouts of inflammation following treatment with the caspase-1
inhibitor YVAD, demonstrating a conserved role for this enzyme
and for P2X7 in zebrafish immunity. Because apoptosis is widely
regarded as an anti-inflammatory event (Fadok et al., 1992), it might
be expected that inhibition of apoptosis with qVD leads to a
reduction in apoptotic cells at the wound site, resulting in a net
increase in the inflammatory burden at the site of injury, masking
any underlying inhibition of IL-1β production. We also describe the
reduction of IL-1β transcription following tissue injury by treatment
with inhibitors of the IL-1 pathway, indicating that IL-1 amplifies
the inflammatory response through further downstream IL-1
induction, similar to mammalian models. We were unable to detect
the same reduction in expression of IL-8 and ptgs2b in response to
injury, suggesting that both IL-1-dependent and IL-1-independent
pathways regulate proinflammatory gene transcriptions in vivo.
The structural conservation of IL-1β between humans and
zebrafish, alongside the induction of IL-1β in leukocytes following
injury and the ability of inhibitors of mammalian caspase-1 and
P2X7 to attenuate inflammation support the functional conservation
of IL-1β signalling between mammalian and teleost lineages. Here,
we demonstrate the versatility and unique advantages of the
zebrafish model in studying the IL-1β pathway in vivo. The use of
transgenic zebrafish lines to directly visualise inflammation offers
exciting future opportunities to observe IL-1β function in vivo.
MATERIALS AND METHODS
Transgenic line generation and maintenance
Tg(mpeg1:Gal4.VP-16)sh256 and Tg(pNF-κB:EGFP)sh235 were
generated as previously described (Ellett et al., 2011; Kanther et al., 2011).
Tg(mpx:EGFP)i114 zebrafish were used to study neutrophils during
inflammation (Renshaw et al., 2006). Zebrafish strains were maintained
on a 14:10-hour light/dark cycle at 28°C as described (Nüsslein-Volhard
and Dahm, 2002) in UK Home Office approved facilities in the MRC
Centre for Developmental and Biomedical Genetics aquaria at the
University of Sheffield. Tg(mpeg1:Gal4.VP-16)sh256 was crossed to
Tg(UAS:Kaede)s1999t to enable visualisation of macrophages.
Expression analysis
Zebrafish IL-1β (GenBank accession: AY340959.1) was cloned using 20 bp
complementary primers (drIL-1βF: 5′-ATGGCATGCGGGCAATATGA-3′,
drIL-1βR: 5′-CTAGATGCGCACTTTATCCT-3′) into dual promoter TOPO
TA (Life Technologies, UK). Digoxigenin-labelled sense and antisense RNA
probes were synthesised (Roche Diagnostics, UK) and WISH performed as
previously described (Nüsslein-Volhard and Dahm, 2002). For antibody,
TSA and FISH staining, the protocol was adapted from Prajsnar et al.
(Prajsnar et al., 2012). Larvae were fixed in 4% w/v paraformaldehyde in
PBS overnight at 4°C. Fixed larvae were briefly washed twice in PBS.
Larvae were incubated in 1:50 TSA Cyanine5 (Perkin Elmer, UK) without
light for 10 minutes at 28°C. Larvae were re-fixed for 20 minutes and
endogenous peroxidase activity quenched with a 1-hour incubation in 0.3%
H2O2. Larvae were probed for IL-1β mRNA as described in Elworthy et al.
(Elworthy et al., 2008) for FISH using anti-digPOD (at 1:10,000) and TSA
Cyanine3. The larvae were then stained with an anti-L-plastin antibody as
described (Feng et al., 2010) using an Alexa-Fluor-488 anti-rabbit secondary
antibody.
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Fig. 2. Leukocyte recruitment to the site of injury is reduced by
treatment with inhibitors of the IL-1β pathway. (A,C) Zebrafish embryos
treated with 50 μM YVAD showed reduced mpeg1:gal4;UAS:Kaede-labelled
macrophage (A) and mpx:EGFP-labelled neutrophil (C) recruitment to the
site of injury after 6 hours compared with DMSO-treated controls. qVD (50
μM) had no effect on leukocyte recruitment. (B,D) Both macrophage and
neutrophil recruitment was also inhibited by treatment with P2X7 inhibitors
KN62 (10 μM) and Brilliant Blue G (1 μM). *P≤0.05, **P≤0.01 by one-way
ANOVA with Dunnett’s post-test, n=24 performed as three independent
experiments.
Fig. 3. Caspase-1 inhibitor YVAD downregulates NF-
κB activation in response to injury. (A) Fluorescence
photomicrograph of pNF-κB:EGFP embryos following
tailfin transection at 1 hpi (i) and 8 hpi (ii) indicating the
region quantified (square bracket). Scale bars: 100 μm.
(B) There is a 2.4-fold increase in EGFP fluorescence in
response to injury, quantifiable as average fluorescent
intensity across the transection site (indicated in A).
****P≤0.0001 by t-test. (C) Embryos treated with 50 μM
YVAD show a reduction in EGFP fluorescence at 8 hpi
compared with DMSO-treated controls and embryos
treated with qVD. **P≤0.01 by one-way ANOVA with
Dunnett’s post-test. n=30 performed as three
independent experiments.
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Fixed-sample imaging
Low-resolution images were acquired using a Nikon SMZ1500
stereomicroscope with a DS-Fi1 camera using NIS elements software
(Nikon, Japan). Higher-resolution images were acquired on glycerol-
mounted embryo tails and imaged on a Bx51 compound microscope, with
a Camedia C-3030ZOOM camera using a 40× NA 1.15 water-immersion
objective and Cell B software (Olympus, UK). FISH images were acquired
on mounted embryo tails using an UltraVIEW VoX spinning disk confocal
microscope (Perkin Elmer) on a Axiovert 200M (Zeiss, UK) running
Volocity™ software for image acquisition (Perkin Elmer) and using a 40×
PlanFLN NA 1.3 oil-immersion objective.
Agilent microarray expression analysis
Six adult Tg(mpx:GFP)i114 fish were macerated using a scalpel and passed
through a series of graded μm meshes, dissociating the tissue. Cells were
sorted by FACS analysis into cells showing neutrophil-like side scatter
(SSC) and forward scatter (FSC), and further sorted into GFP-positive and
-negative (control) sets. RNA was extracted using the mirVana™ kit (Life
Technologies). Microarray analysis was performed using a Zebrafish (V3)
Gene Expression Microarray containing 43663 probes (Agilent
Technologies, The Netherlands).
3D-structure prediction
The 3D model of zebrafish IL-1β was generated by submitting the protein
sequence (accession: NP_998009.1) to the Phyre Server (Kelley and
Sternberg, 2009).
Treatment with IL-1β-pathway inhibitors
Embryos were pre-treated with compounds as described, for 2 hours before
injury. Embryos were injured by tail transection at the distal-most point of
the pigment gap at 3 dpf as described (Renshaw et al., 2006) and neutrophil
or macrophage numbers at the site of injury counted at 6 hpi. Tg(pNF-
κB:EGFP)sh235 embryos were injured as described, mounted in 0.75%
LMP agarose at 8 hpi and imaged with a 10× NA 0.3 objective using a TE-
2000U microscope (Nikon) and an Orca-AG camera (Hamamatsu, Japan)
using Volocity™. The mean fluorescent intensity was measured between the
line of injury and proximal end of the pigment gap, ignoring neuromasts,
using Volocity™ for quantification.
Analysis of gene expression
Leukocyte-specific RNA was obtained by dissociating mpeg:gal4;UAS:Kaede
or mpx:GFP embryos in PBS with 0.4% trypsin on an orbital shaker for 1
hour with frequent trituration using a pipette. Cells were sorted by FACS
analysis and RNA extracted using an RNA Isolate II micro kit (Bioline, UK).
Tail-tissue RNA was obtained as described (de Oliveira et al., 2013) using
Superscript 2 (Invitrogen). qRT-PCR was performed on a CFX96 detection
system (Bio-Rad, UK) using Dynamo Flash SYBR green mastermix (Thermo
Scientific, UK) using primers described in de Oliveira et al. (de Oliveira et al.,
2013).
Statistical analysis
Data were analysed using Prism 6 (Graphpad, USA). Data shown are mean
± s.e.m. using multiple t-tests with a Bonferroni correction or one-way
ANOVA with Dunnet’s post-test.
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